QUVIVIQ has long been researched in mild to intense OSA not using CPAP, and in patients with average COPD. The results of QUVIVIQ on respiratory perform should be regarded as if prescribed to people with compromised respiratory perform. QUVIVIQ has not been researched in sufferers with gentle or extreme COPD.The typical doses are 10mg, 20mg, or 40m